Regulatory Affairs Director
Medtronic
Angie Noah, PhD is a Regulatory Affairs Director at Medtronic, serving within the Cardiac Rhythm Management (CRM) business. With over nine years of experience on the CRM Regulatory team, Angie leads a global team overseeing regulatory strategies for both medium- and high-risk medical devices, including implantable diagnostics, software as a medical device (SaMD), and device programmers and monitors. Her leadership has been instrumental in securing the first FDA approval for a pan-PMA Post-Approval Change Protocol (PCCP), enabling streamlined regulatory pathways for select manufacturing changes to PMA products. Angie is passionate about mentoring early career professionals and ensuring global access to safe and effective products.
Accelerating Postmarket Innovation with Predetermined Change Control Plans (PCCPs): AI/ML and Beyond
Thursday, October 9, 2025
1:00 PM - 2:00 PM EST